Evidence-based dry-eye therapies for clinical use
8 October 2021
Volume 22, Issue 3
This article outlines a range of dry-eye disease management strategies available at each severity level and between subtypes of the disease.
Domains covered
Professionalism
Clinical practice
Specialty CPD (IP)
Despite recent advances in the management and treatment of dry-eye disease, the condition is still managed differently across continents and countries. From diagnosis to disease progression and treatment, patients should be well informed about the safe and effective use of available therapies. Consequently, this article aims to appraise eye care practitioners of a wide range of management strategies available at each severity level and between subtypes of dry-eye disease.
Sign in to view the article
Not a member? Start enjoying the benefits of College membership today. Take a look at what the College can offer you and view our membership categories and rates.
Related further reading
This in-person peer review in Belfast is free of charge for College members and will cover your peer review CPD requirement, offering 3 CPD points.
Artificial intelligence could be used to predict heart disease risk using a retinal photograph. But, Kim Thomas asks, is it an opportunity for optometrists to extend their skill-set – or an unwelcome addition to their workload?
Kathy Oxtoby looks at the intended and adverse effects of corticosteroids, the common concerns patients have, and how to manage a steroid response.